Safety and Immunogenicity of a Delayed Heterologous Avian Influenza A(H7N9) Vaccine Boost Following Different Priming Regimens: A Randomized Clinical Trial.
Saved in:
| Title: | Safety and Immunogenicity of a Delayed Heterologous Avian Influenza A(H7N9) Vaccine Boost Following Different Priming Regimens: A Randomized Clinical Trial. |
|---|---|
| Authors: | El Sahly HM; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA.; Department of Medicine, Baylor College of Medicine, Houston, Texas, USA., Yildirim I; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA., Frey SE; Department of Internal Medicine, Saint Louis University School of Medicine, St Louis, Missouri, USA., Winokur P; Department of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA., Jackson LA; Kaiser Permanente Washington Health Research Institute, Seattle, Washington, USA., Bernstein DI; Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio, USA., Creech CB; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Chen WH; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA., Rupp RE; Sealy Institute for Vaccine Sciences, University of Texas Medical Branch, Galveston, Texas, USA., Whitaker JA; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA.; Department of Medicine, Baylor College of Medicine, Houston, Texas, USA., Phadke V; The Hope Clinic of Emory University, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia, USA., Hoft DF; Department of Internal Medicine, Saint Louis University School of Medicine, St Louis, Missouri, USA., Ince D; Department of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA., Brady RC; Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio, USA., Edwards KM; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Ortiz JR; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA., Berman MA; Sealy Institute for Vaccine Sciences, University of Texas Medical Branch, Galveston, Texas, USA., Weiss J; The Emmes Company, Rockville, Maryland, USA., Wegel A; The Emmes Company, Rockville, Maryland, USA. |
| Corporate Authors: | DMID 17-0090 Study Group |
| Source: | The Journal of infectious diseases [J Infect Dis] 2024 Feb 14; Vol. 229 (2), pp. 327-340. |
| Publication Type: | Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1537-6613 |
|---|---|
| DOI: | 10.1093/infdis/jiad276 |
